Comparison of adjuvants to optimize influenza neutralizing antibody responses-Reference-Cited by-同舟云学术

Comparison of adjuvants to optimize influenza neutralizing antibody responses

Published:2019-09 Issue:42 Volume:37 Page:6208-6220
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Rudicell Rebecca S.,Garinot Marie,Kanekiyo Masaru^ORCID,Kamp Heather D.,Swanson Kurt,Chou Te-hui,Dai Shujia,Bedel Olivier,Simard Daniel,Gillespie Rebecca A.,Yang Kanwen,Reardon Michael,Avila Luis Z.,Besev Magnus,Dhal Pradeep K.,Dharanipragada Ram,Zheng Lingyi,Duan Xiaochu,Dinapoli Joshua,Vogel Thorsten U.,Kleanthous Harry,Mascola John R.,Graham Barney S.,Haensler Jean,Wei Chih-Jen,Nabel Gary J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference109 articles.

1. An overview of the regulation of influenza vaccines in the United States;Weir;Influenza Other Respir Viruses,2016

2. Novel universal influenza virus vaccine approaches;Krammer;Curr Opin Virol,2016

3. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans;Garten;Science,2009

4. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains;Zost;Proc Natl Acad Sci USA,2017

5. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine;Wu;PLoS Pathog,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle targeting cGAS-STING signaling in disease therapy;Nano Research;2024-06-15

2. Research progress on emulsion vaccine adjuvants;Heliyon;2024-02

3. Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes;PLOS Pathogens;2023-08-28

4. Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG;Pharmaceutics;2023-03-10

5. Modulation of type I interferon signaling by natural products in the treatment of immune-related diseases;Chinese Journal of Natural Medicines;2023-01